CLINICAL TRIALS PROFILE FOR LASTACAFT
✉ Email this page to a colleague
All Clinical Trials for LASTACAFT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01470118 ↗ | A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis | Completed | Allergan | Phase 4 | 2011-10-01 | This study will evaluate the duration of action of LASTACAFT® and Pataday™ as compared to artificial tears (placebo) in the prevention of ocular itching associated with allergic conjunctivitis. |
NCT01732757 ↗ | A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis | Completed | Allergan | Phase 4 | 2012-11-01 | This study will evaluate the efficacy of Lastacaft® (Alcaftadine 0.25%) and Pataday™ (Olopatadine 0.2%) as compared to each other and to placebo in the prevention of ocular itching associated with allergic conjunctivitis. |
NCT01808768 ↗ | Ocular Allergy Treatment Practical Impact Trial | Unknown status | Starx Research Center, LLC | Phase 4 | 2013-04-01 | To study the impact of alcaftadine in patients treated with other opthalmic ocular agents (or specific topical opthalmic treatment) in an allergy subspecialist outpatient setting. |
NCT02308501 ↗ | A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy | Completed | ORA, Inc. | Phase 4 | 2014-12-01 | A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft ® as Measured by In-Vivo Confocal Microscopy |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LASTACAFT
Condition Name
Clinical Trial Locations for LASTACAFT
Trials by Country
Clinical Trial Progress for LASTACAFT
Clinical Trial Phase
Clinical Trial Sponsors for LASTACAFT
Sponsor Name